Biography and Research Information
OverviewAI-generated summary
Rahaf Omaish's research focuses on understanding adverse events and treatment outcomes in patients undergoing complex medical interventions, particularly CAR T-cell therapy and kidney transplantation. Her work investigates risk factors and clinical characteristics associated with conditions like acute kidney injury (AKI) and immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR T-cell recipients. Omaish also examines diagnostic challenges, such as post-transplant lymphoproliferative disorder (PTLD) following negative biopsies, and explores treatment outcomes for specific conditions like recurrent dense deposit disease after kidney transplant. Additionally, her research includes evaluating immunohistochemistry staining for biomarkers like B-cell maturation antigen (BCMA) in multiple myeloma patients who have previously received BCMA-based therapies. Omaish collaborates with researchers at the University of Arkansas for Medical Sciences, including Lean Alkhatib and Abedalrahman Almashayekh, with whom she has co-authored multiple publications.
Metrics
- h-index: 1
- Publications: 7
- Citations: 1
Selected Publications
-
Potential of Triple Therapy in Diabetic Kidney Disease (2025)
-
AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics (2025)
-
Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients (2025)
-
Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy (2025)
-
Iptacopan treatment for recurrent dense deposit disease after kidney transplant: A case report (2025)
-
MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma. (2025)
-
B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies. (2025)
Collaboration Network
Top Collaborators
Lean Alkhatib
University of Arkansas for Medical Sciences
3 shared publications
In database
- Iptacopan treatment for recurrent dense deposit disease after kidney transplant: A case report
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
Abedalrahman Almashayekh
University of Arkansas for Medical Sciences
3 shared publications
In database
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
Neriman Gokden
University of Arkansas for Medical Sciences (US)
2 shared publications
- Iptacopan treatment for recurrent dense deposit disease after kidney transplant: A case report
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
Zelalem Mekuria
University of Arkansas for Medical Sciences
2 shared publications
In database
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
Nishank Jain
University of Arkansas for Medical Sciences
2 shared publications
In database
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
Carolina Schinke
University of Arkansas for Medical Sciences
1 shared publication
In database
- B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies.
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
1 shared publication
In database
- B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies.
Maurizio Zangari
University of Arkansas for Medical Sciences
1 shared publication
In database
- B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies.
Frits van Rhee
Winthrop Rockefeller Foundation (US)
1 shared publication
- B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies.
Samer Al Hadidi
University of Arkansas for Medical Sciences
1 shared publication
In database
- B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies.
Sushma Bhusal
University of Arkansas for Medical Sciences
1 shared publication
In database
- Iptacopan treatment for recurrent dense deposit disease after kidney transplant: A case report
Venkata Manchala
University of Arkansas for Medical Sciences
1 shared publication
In database
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
Nithin Karakala
University of Arkansas for Medical Sciences
1 shared publication
In database
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
J. Curran Henson
University of Arkansas for Medical Sciences
1 shared publication
In database
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
Sruthi Vellanki
University of Arkansas for Medical Sciences (US)
1 shared publication
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
Similar Researchers
Based on overlapping research topics
Tanvi Patel
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies
Lean Alkhatib
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Organ Transplantation Techniques and Outcomes
Pharmacological Effects and Toxicity Studies
Nishanth Thalambedu
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Organ Transplantation Techniques and Outcomes
Multiple Myeloma Research and Treatments
Jaskirat Sethi
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies
Ramya Bachu
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies
Munawwar Hussain
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies